Apryl, Berlin-based fertility benefits platform, has grabbed €4.1 million in seed funding. The investment round was led by Breega alongside participation from other investors, including Crista Galli Ventures, Myelin VC, Alliance For Impact Ventures and Westtech Ventures. Also, existing investor Atlantic Labs that recently invested in Choco and Levy Health took part in the round.
The proceeds of this round will be used to fuel Apryl’s next stage of growth. The company is now focused on hiring fresh talent in product, operations, sales and marketing to strengthen and reinforce its unique position in the European market.
CEO Jenny Saft commented: “We created Apryl because we believe that everyone should have the same chances to start a family – whatever their age, gender, sexual orientation, relationship status or financial means. Companies today have a key role to play in helping employees on their path to parenthood. To remain competitive, they must demonstrate a family-first culture and a willingness to support their employees in this critical life phase. We believe that to win the war for talent, businesses must show they can tackle the problems that really matter to millennials. Apryl’s fertility benefits platform allows them to do just that”.
Victor Drault, Principal at Breega commented: “Tobi and Jenny’s solution speaks to a growing issue for both today and tomorrow’s workforce. At Breega, we strongly believe in their vision, we also believe that providing them with the right operational support – thanks to the Breega Scaling squad – will transform that vision into reality, helping them to become a global category leader in the fertility benefits space.”
Lukas Erbgut, Director Atlantic Labs said, “We are strong believers in the fertility space and have supported Jenny and Tobi from the very early days, and we are very excited to see them move to the next phase.”
Fiona Pathiraja, Managing Director, Crista Galli Ventures, said, “The current health care sector in Europe is lacking as regards fertility and family forming support. Enabling better care access through the employer benefits angle is an important step.”
First pan-European fertility benefits platform
Apryl was founded by Jenny Saft and Tobias Kaufhold in late 2019 in Berlin. The founders observed that Europeans are now having children later in life, and the fertility rates are continuing to decline with age. Given that fertility treatments remain a costly experience, they developed the pioneering family forming benefits platform.
It has built the first pan-European fertility benefits platform that enables companies to support employees on their path to parenthood. The fertility and family forming benefits platform enables companies to support their employees on their path to parenthood.
These benefits include subsidies for care navigation, consultations, access to clinics and treatments such as egg/sperm freezing, IVF, adoption or surrogacy. It believes that everyone should have the same chances to start a family, irrespective of their age, gender, sexual orientation, relationship status or financial means.
